See up to 3 months of CGC. The 7-day demo opens the 1M and 3M ranges and puts CGC on your watchlist.
Start 7-day demoLatest CGC insider trades
About Canopy Growth Corp (CGC)
Canopy Growth Corp files with the SEC under CIK 0001737927 and is classified as medicinal chemicals and botanical products. We track it alongside the rest of the Health Care sector.
CGC Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 7 | 84,822 | $87K |
CGC insider transactions (Form 4)
3740 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Theresa Yanofsky - Director | Open-market sale | Common Shares | 14,920 footnote F1 | $0.93 | $14K | |
| ||||||
| David Angelo Lazzarato - Director | Open-market sale | Common Shares | 22,380 footnote F1 | $0.93 | $21K | |
| ||||||
| Open-market sale | Common Shares | 3,096 footnote F1 | $0.93 | $3K | ||
| ||||||
| M. Shan Atkins - Director | Open-market sale | Common Shares | 3,096 footnote F1 | $0.93 | $3K | |
| ||||||
| Thomas Carlton Stewart - Officer | Open-market sale | Common Shares | 25,755 footnote F1 | $0.93 | $24K | |
| ||||||
| Christelle Gedeon - Officer | Open-market sale | Common Shares | 13,344 footnote F1 | $1.47 footnote F2 | $20K | |
| ||||||
| Thomas Carlton Stewart - Officer | Open-market sale | Common Shares | 2,231 footnote F1 | $1.47 footnote F2 | $3K | |
| ||||||
| Open-market sale | Common Shares | 3,197 footnote F1 | $0.92 | $3K | ||
| ||||||
| Theresa Yanofsky - Director | Open-market sale | Common Shares | 15,054 footnote F1 | $0.92 | $14K | |
| ||||||
| M. Shan Atkins - Director | Open-market sale | Common Shares | 3,197 footnote F1 | $0.92 | $3K | |
| ||||||
| David Angelo Lazzarato - Director | Open-market sale | Common Shares | 22,674 footnote F1 | $0.92 | $21K | |
| ||||||
| M. Shan Atkins - Director | Grant or award | Common Shares | 108,324 footnote F1 | $0.00 | - | |
| ||||||
| David Angelo Lazzarato - Director | Grant or award | Common Shares | 162,485 footnote F1 | $0.00 | - | |
| ||||||
| Grant or award | Common Shares | 108,324 footnote F1 | $0.00 | - | ||
| ||||||
| Theresa Yanofsky - Director | Grant or award | Common Shares | 108,324 footnote F1 | $0.00 | - | |
| ||||||
| Thomas Carlton Stewart - Officer | Open-market sale | Common Shares | 9,285 footnote F2 | $0.97 | $9K | |
| Thomas Carlton Stewart - Officer | Grant or award | Stock Option | 463,347 | $0.00 | - | |
| Thomas Carlton Stewart - Officer | Grant or award | Common Shares | 379,018 footnote F1 | $0.00 | - | |
| ||||||
| Christelle Gedeon - Officer | Grant or award | Common Shares | 396,012 footnote F1 | $0.00 | - | |
| Christelle Gedeon - Officer | Open-market sale | Common Shares | 58,994 footnote F2 | $0.97 | $57K | |
| Christelle Gedeon - Officer | Grant or award | Stock Option | 484,122 | $0.00 | - | |
| ||||||
| Luc Mongeau - Officer | Grant or award | Stock Option | 1,291,139 | $0.00 | - | |
| Luc Mongeau - Officer | Grant or award | Common Shares | 1,056,152 footnote F1 | $0.00 | - | |
| Luc Mongeau - Officer | Open-market sale | Common Shares | 135,231 footnote F2 | $0.97 | $132K | |
| ||||||
| Theresa Yanofsky - Director | Open-market sale | Common Shares | 10,373 footnote F1 | $0.93 | $10K | |
| ||||||
| M. Shan Atkins - Director | Open-market sale | Common Shares | 2,074 footnote F1 | $0.93 | $2K | |
| ||||||
| Open-market sale | Common Shares | 2,658 footnote F1 | $0.93 | $2K | ||
| ||||||
| David Angelo Lazzarato - Director | Open-market sale | Common Shares | 15,624 footnote F1 | $0.93 | $15K | |
| ||||||
| Luc Mongeau - Officer | Open-market sale | Common Shares | 9,376 footnote F1 | $1.06 footnote F2 | $10K | |
| ||||||
| David Angelo Lazzarato - Director | Open-market sale | Common Shares | 15,677 | $1.58 | $25K | |
| Theresa Yanofsky - Director | Open-market sale | Common Shares | 10,408 | $1.58 | $16K | |
| Willy Kruh - Director | Open-market sale | Common Shares | 10,451 | $1.58 | $17K | |
| M. Shan Atkins - Director | Open-market sale | Common Shares | 2,216 | $1.58 | $4K | |
| Luc Mongeau - Officer | Open-market purchase | Common Shares | 27,469 | $1.82 | $50K | |
| Thomas Carlton Stewart - Officer | Grant or award | Common Shares | 178,462 | $0.00 | - | |
| Thomas Carlton Stewart - Officer | Grant or award | Stock Option | 222,280 | $0.00 | - | |
| Thomas Carlton Stewart - Officer | Open-market sale | Common Shares | 5,768 | $1.74 | $10K | |
CGC insider trading FAQ
What is the latest insider trade for CGC?
Canopy Growth Corp (CGC) had 7 insider filings in the last 90 days, with the most recent on 2026-09-30. The full record for CGC runs to 40 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CGC stock?
No insider purchases of CGC were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling CGC stock?
7 insider sales of CGC were filed in the last 90 days, totaling $87K.
Where can I see CGC SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CGC Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Theresa Yanofsky view on EDGAR
- - David Angelo Lazzarato view on EDGAR
- - Joseph Bayern view on EDGAR
- - M. Shan Atkins view on EDGAR
- - Thomas Carlton Stewart view on EDGAR
- - Christelle Gedeon view on EDGAR
- - Thomas Carlton Stewart view on EDGAR
- - Joseph Bayern view on EDGAR
- - Theresa Yanofsky view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Insider activity in Health Care
- Where CGC's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CGC with a 7-day demo
- CGC on your watchlist
- Every CGC Form 4 filing on record
- Up to 3 months of CGC price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive